top of page

Protecting Brain and
Vital Organ Health

in Neonates and Infants Worldwide 

preterm neonate of 970 g with OxyPrem NOAH sensor

Latest Technology
for Newborns

Advanced Algorithms

Reusable High-Precision Sensors

Designed
for Smallest Patients 

preterm neonate with OxyPrem 1.4 sensor

A Summary of
Challenges

Just 5 minutes 

of inadequate oxygenation are enough to cause permanent brain damage. 

46% of survivors

of severe prematurity suffer from life-long consequences.

At OxyPrem, we provide precise and accurate brain oxygen monitoring, so that medical teams can react before damage occurs.

Latest News

OxyPrem at "10 vor 10", with crowd campaign incentive

November 2024

OxyPrem will be featured on the popular TV news magazine "10 vor 10" on Swiss station "SRF 1" on November 1st, 21:50 CET. Tune in for an OxyPrem "behind the scenes" and to see our OxyPrem 1.4 system outside the typical ICU application - in music therapy! 

.

After its airtime, the broadcast can also be watched at https://www.srf.ch/play/tv/sendung/10-vor-10?id=c38cc259-b5cd-4ac1-b901-e3fddd901a3d (in German/Swiss German language), even from outside Switzerland.

.

To reflect this in our crowd investing campaign at https://capitalcell.com/en/campaign/oxyprem/ , the following "10-themed" incentive is now active on the campaign website:

  • OxyPrem featured on "10 vor 10"...

  • ...therefore, investments of at least 5.000 EUR receive a 10% reduction in share price

  • incentive runs until November 10th.

Information for current investors:

  • If you already have invested 5.000 EUR or more, you will be contacted by Capital Cell to adapt to the new conditions. 

  • If you want to increase your existing investment to 5.000 EUR or more, you receive the 10% reduction on your entire investment. Please write to campaign@oxyprem.com - the OxyPrem and Capital Cell teams will help you with the process.

Become an OxyPrem investor today and help us protect the brains of high-risk patients!



Crowdinvesting campaign hits 70% and approaches 100 investors

October 2024

Our crowd investment campaign, running on https://capitalcell.com/en/campaign/oxyprem/, is progressing. 70% of the campaign goal has been committed, and the campaign is soon to cross the 100-investor mark

.

Additionally, the Capital Cell team invited our CEO Alexander Nitsch to an interview in their "Meet the Founder" video series. The video is available in English with subtitles in various languages at https://www.youtube.com/watch?v=bXHAKPfnukM .

.

Invest in OxyPrem today and become part of our journey!

Our Mission
Our non-invasive sensors offer real-time insight into tissue oxygen levels. This enables early intervention to prevent brain and other organ damage.

We are proud of our supporters

Dive Deeper.

More insights about our products.

Long-standing wish

A next-generation device for high-technology tissue oximetry has been a longstanding request by the clinical community.

Fragile patients

Premature children belong to the most vulnerable patient groups and require extra careful handling and treatment. 

bottom of page